Protection from cyclophosphamide-induced ovarian damage with bone marrow-derived mesenchymal stem cells during puberty

References

• Schilsky RL, Lewis BJ, Sherins RJ, & Young RC. Gonadal dysfunction in patients receiving chemotherapy for cancer. Ann Intern Med 1980;93:109–14
   PubMed Web of Science ®Google Scholar
• Chapman RM, Sutcliffe SB, Malpas JS. Cytotoxic-induced ovarian failure in women with hodgkin's disease. I. Hormone function. JAMA 1979;242:1877–81
   PubMed Web of Science ®Google Scholar
• Ries Lag MD, Krapcho M, Stinchcomb DG, et al. Seer cancer statistics review. National Cancer Institute 2008
   Google Scholar
• Hudson M. Reproductive outcomes for survivors of childhood cancer. Obstet Gynecol 2010;116:1171–83
   PubMed Web of Science ®Google Scholar
• Mackie EJ, Radford M, Shalet SM. Gonadal function following chemotherapy for childhood Hodgkin's disease. Med Pediatr Oncol 1996;27:74–8
   PubMedGoogle Scholar
• Clark ST, Radford JA, Crowther D, et al. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of mvpp and a seven-drug hybrid regimen. J Clin Oncol 1995;13:134–9
   PubMed Web of Science ®Google Scholar
• Byrne J. Infertility and premature menopause in childhood cancer survivors. Med Pediatr Oncol 1999;33:24–8
   PubMedGoogle Scholar
• Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol 1999;33:2–8
   PubMedGoogle Scholar
• Eliopoulos N, Zhao J, Forner K, et al. Erythropoietin gene-enhanced marrow mesenchymal stromal cells decrease cisplatin-induced kidney injury and improve survival of allogeneic mice. Mol Ther 2011;19:2072–83
   PubMed Web of Science ®Google Scholar
• Diez Villanueva P, Sanz-Ruiz R, Nunez Garcia A, et al. Functional multipotency of stem cells: what do we need from them in the heart? Stem Cells Int 2012;2012:817364
   PubMedGoogle Scholar
• Seiden MV, Spitzer TR, Mcafee S, Fuller AF. Successful pregnancy after high-dose cyclophosphamide, carboplatinum, and taxol with peripheral blood stem cell transplant in a young woman with ovarian carcinoma. Gynecol Oncol 2001;83:412–14
   PubMed Web of Science ®Google Scholar
• Sanchez PL, Villa A, Sanz R, et al. Present and future of stem cells for cardiovascular therapy. Ann Med 2007;39:412–27
   PubMed Web of Science ®Google Scholar
• Glode LM, Robinson J, Gould SF. Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone. Lancet 1981;1:1132–4
   PubMed Web of Science ®Google Scholar
• Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41–9
   PubMed Web of Science ®Google Scholar
• Bryja JK. A fast sex identification in wild mammals using pcramplification of the sry gene. Folia Zool 2003;52:269–74
   Web of Science ®Google Scholar
• Ise H, Nikaido T, Negishi N, et al. Effective hepatocyte transplantation using rat hepatocytes with low asialoglycoprotein receptor expression. Am J Pathol 2004;165:501–10
   PubMed Web of Science ®Google Scholar
• Chemaitilly W, Mertens AC, Mitby P, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 2006;91:1723–8
   PubMed Web of Science ®Google Scholar
• Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 2005;6:209–18
   PubMed Web of Science ®Google Scholar
• Sklar C. Maintenance of ovarian function and risk of premature menopause related to cancer treatment. J Natl Cancer Inst Monogr 2005;(34):25–7
   Google Scholar
• Oktay K, Turkcuoglu I, Rodriguez-Wallberg KA. Four spontaneous pregnancies and three live births following subcutaneous transplantation of frozen banked ovarian tissue: what is the explanation? Fertil Steril 2011;95:804.e7–10
   PubMed Web of Science ®Google Scholar
• Sonmezer M, Oktay K. Orthotopic and heterotopic ovarian tissue transplantation. Best Pract Res Clin Obstet Gynaecol 2010;24:113–26
   PubMed Web of Science ®Google Scholar
• Johnson J, Canning J, Kaneko T, et al. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004;428:145–50
   PubMed Web of Science ®Google Scholar
• Flaws JA, Abbud R, Mann RJ, et al. Chronically elevated luteinizing hormone depletes primordial follicles in the mouse ovary. Biol Reprod 1997;57:1233–7
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z, Dann E, Avivi I, et al. M. Fertility after treatment for hodgkin's disease. Ann Oncol 2002;13:138–47
   Google Scholar
• Ataya K, Rao LV, Lawrence E, Kimmel R. Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol Reprod 1995;52:365–72
   PubMed Web of Science ®Google Scholar
• Badawy A, Elnashar A, El-ashry M, Shahat M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril 2009;91:694–7
   PubMed Web of Science ®Google Scholar
• Pereyra Pacheco B, Mendez Ribas JM, Milone G, et al. Use of gnrh analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report. Gynecol Oncol 2001;81:391–7
   PubMed Web of Science ®Google Scholar
• Sverrisdottir A, Nystedt M, Johansson H, Fornander T. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res Treat 2009;117:561–7
   PubMed Web of Science ®Google Scholar
• Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer SM. Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis. Breast Cancer Res Treat 2010;122:803–11
   PubMed Web of Science ®Google Scholar
• Del Mastro L, Catzeddu T, Boni L, et al. Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann Oncol 2006;17:74–8
   PubMed Web of Science ®Google Scholar
• Demeestere I, Brice P, Peccatori FA, et al. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. J Clin Oncol 2013;31:903–9
   PubMed Web of Science ®Google Scholar
• Toft E., Becedas L, Soderstrom M, et al. Glutathione transferase isoenzyme patterns in the rat ovary. Chem Biol Interact 1997;108:79–93
   PubMedGoogle Scholar
• Rahilly M, Carder PJ, Al Nafussi A, Harrison DJ. Distribution of glutathione s-transferase isoenzymes in human ovary. J Reprod Fertil 1991;93:303–11
   PubMedGoogle Scholar
• Gamcsik MP, Dolan ME, Andersson BS, Murray D. Mechanisms of resistance to the toxicity of cyclophosphamide. Curr Pharm Des 1999;5:587–605
   PubMed Web of Science ®Google Scholar
• Oktay K, Sonmezer M, Oktem O, et al. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist 2007;12:1055–66
   PubMed Web of Science ®Google Scholar
• Guth PH, Paulsen G. Aspirin-induced gastric injury in the rat: histologic changes and sucralfate cytoprotection. Proc Soc Exp Biol Med 1987;184:423–8
   PubMedGoogle Scholar
• Li HC, Stoicov C, Rogers AB, Houghton J. Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol 2006;12:363–71
   PubMed Web of Science ®Google Scholar
• Lee HJ, Selesniemi K, Niikura Y, et al. Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure. J Clin Oncol 2007;25:3198–204
   PubMed Web of Science ®Google Scholar
• Takehara Y, Yabuuchi A, Ezoe K, et al. The restorative effects of adipose-derived mesenchymal stem cells on damaged ovarian function. Lab Invest 2013;93:181–93
   PubMed Web of Science ®Google Scholar
• Fu X, He Y, Xie C, Liu W. Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage. Cytotherapy 2008;10:353–63
   PubMed Web of Science ®Google Scholar